Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 意见
• 07/17/23
0
0
嵌入
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论